Jan "Butch" Patrick Schade of San Diego passed away peacefully at home on Sunday, June 29, 2008, he was surrounded by his loved ones. Butch was born on February 11, 1970 and raised in Cranford, New Jersey, before moving to San Diego. He was an avid surfer, loved motorcycles and had a passion for classic cars. He was employed as an estimator at Magnesite Specialties, Inc.
Under different forms, antioxidants are in wide use among health-conscious people and even more so among cancer patients. They take the form of such dietary supplements as Vitamin C, E and A, beta-carotene, lycopene, selenium, ginger (Zingiber officinale), cucurmin (turmeric), or pomegranate juice.
Joseph Mark Trinca, 58, passed away peacefully in his home with his wife and two daughters at his bedside on Monday, June 16, 2008. Joe was born on September 26, 1949 in Fulton, Kentucky to Peter Joseph Trinca, M.D. and Mary Jean Stahr Trinca. He grew up in El Dorado, Arkansas and graduated from Cascia Hall in Tulsa, Oklahoma.
In November 2000, just after her 16th wedding anniversary with husband, Michael, Elsie Hernandez’s CT scan showed a mass that appeared to be pancreatic cancer; immediate surgery was needed. Elsie, a mathematician, told her students at [...]
This is a follow-up to an article published in the May 2008 newsletter highlighting the benefits and risks involved in MRIs, PET and CT scans. In the offices of the Life Raft Group, we receive [...]
Anthony "Tony", Director of Sales for Maxell Corporation of America's Professional Products Division, passed away on Friday May 23, 2008. He was 58 years old. The entire magnetic recording media community joins the Petruzziello family in mourning the passing of the man whose accomplishments over the past 33 years are unparalleled. Born on September 29, 1949,
Recently, concerns about exposure to radiation during scans have stirred significant discussion in the LRG email community. Although this is a decision that must be made between each individual and their treatment team, it [...]
Since 2001 GIST treatment has benefited from blocking a single mutant protein, c-KIT. Targeting c-KIT with Gleevec and Sutent has led to years of extended survival for many GIST patients. Unfortunately, cancer is an adaptive [...]
Nick Lydon, Ph.D. discovered and co-developed the leukemia drug Gleevec. In this discussion, which is part of the Frontiers In Cancer Research series of talks at UC Santa Barbara, Lydon talks about the scientific process of discovering this drug and how it was tested to determine its effectiveness in battling leukemia.
The legal battle that had been waged by the Abigail Alliance since 2003 ended abruptly on January 14 when the Supreme Court refused to hear the appeal by the patient advocates. Currently, it is illegal [...]
